Processes

Develop and validate new medical technologies

How develop and validate new medical technologies are reshaped as AGI capability advances.

ProcessesDevelop and validate new medical technologies
Develop and validate new medical technologies — illustrated

Business-as-Code

Read as an executable program — the work decomposed into Code, Generative, Agentic, and Human.

Develop and validate new medical technologies sits inside a larger value-flow — 1 parent structure it composes into. The hierarchy is grounding, not the story: it tells you which aggregate exposure Develop and validate new medical technologies inherits.

Where Develop and validate new medical technologies sits

Related articles

No articles yet for this entity.

Recent capability events

No capability events for this entity yet.

How the work flows

Trigger: An emerging medical technology, digital health application, or novel treatment protocol is identified for potential inclusion in payer coverage.

  1. Identify emerging medical technologies and novel treatments via market and clinical scans
  2. Review clinical evidence for safety and patient efficacy
  3. Perform actuarial and cost-effectiveness analysis
  4. Conduct pilot programs or peer reviews with medical advisory boards
  5. Draft and approve coverage policies and reimbursement rates
  6. Track real-world health outcomes and utilization metrics post-approval

Outcome: The technology is validated for clinical and financial efficacy, culminating in an approved coverage policy or care program integration.

Measured by

Time To Coverage DecisionClinical Evidence Review Cycle TimeCost Per Technology AssessmentPilot Success Rate